Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Felodipine 5mg modified-release tablets
0206020F0AAABAB
|
Felodipine | Felodipine | Cardiovascular System | 297,205 |
|
Felodipine 2.5mg modified-release tablets
0206020F0AAADAD
|
Felodipine | Felodipine | Cardiovascular System | 227,514 |
|
Felodipine 10mg modified-release tablets
0206020F0AAACAC
|
Felodipine | Felodipine | Cardiovascular System | 224,870 |
|
Delofine XL 5mg tablets
0206020F0BNAAAB
|
Delofine | Felodipine | Cardiovascular System | 26,578 |
|
Delofine XL 2.5mg tablets
0206020F0BNACAD
|
Delofine | Felodipine | Cardiovascular System | 22,091 |
|
Delofine XL 10mg tablets
0206020F0BNABAC
|
Delofine | Felodipine | Cardiovascular System | 21,576 |
|
Cardioplen XL 5mg tablets
0206020F0BKAAAB
|
Cardioplen | Felodipine | Cardiovascular System | 17,199 |
|
Cardioplen XL 10mg tablets
0206020F0BKABAC
|
Cardioplen | Felodipine | Cardiovascular System | 15,546 |
|
Cardioplen XL 2.5mg tablets
0206020F0BKACAD
|
Cardioplen | Felodipine | Cardiovascular System | 13,061 |
|
Vascalpha 10mg modified-release tablets (Accord)
0206020F0BIABAC
|
Vascalpha | Felodipine | Cardiovascular System | 8,528 |
|
Vascalpha 5mg modified-release tablets (Accord)
0206020F0BIAAAB
|
Vascalpha | Felodipine | Cardiovascular System | 8,213 |
|
Folpik XL 10mg tablets
0206020F0BGABAC
|
Folpik XL | Felodipine | Cardiovascular System | 1,356 |
|
Folpik XL 5mg tablets
0206020F0BGAAAB
|
Folpik XL | Felodipine | Cardiovascular System | 1,233 |
|
Parmid XL 2.5mg tablets
0206020F0BJACAD
|
Parmid (Felodipine) | Felodipine | Cardiovascular System | 632 |
|
Folpik XL 2.5mg tablets (Teva)
0206020F0BGACAD
|
Folpik XL | Felodipine | Cardiovascular System | 601 |
|
Plendil 10mg modified-release tablets
0206020F0BBABAC
|
Plendil | Felodipine | Cardiovascular System | 537 |
|
Plendil 5mg modified-release tablets
0206020F0BBAAAB
|
Plendil | Felodipine | Cardiovascular System | 470 |
|
Plendil 2.5mg modified-release tablets
0206020F0BBACAD
|
Plendil | Felodipine | Cardiovascular System | 262 |
|
Felotens XL 2.5mg tablets
0206020F0BEACAD
|
Felotens | Felodipine | Cardiovascular System | 131 |
|
Neofel XL 2.5mg tablets (Kent Pharm)
0206020F0BLACAD
|
Neofel | Felodipine | Cardiovascular System | 60 |
|
Neofel XL 5mg tablets
0206020F0BLAAAB
|
Neofel | Felodipine | Cardiovascular System | 40 |
|
Neofel XL 10mg tablets
0206020F0BLABAC
|
Neofel | Felodipine | Cardiovascular System | 35 |
|
Felotens XL 5mg tablets
0206020F0BEAAAB
|
Felotens | Felodipine | Cardiovascular System | 30 |
|
Felotens XL 10mg tablets
0206020F0BEABAC
|
Felotens | Felodipine | Cardiovascular System | 29 |
|
Pinefeld XL 10mg tablets
0206020F0BMAAAC
|
Pinefeld | Felodipine | Cardiovascular System | 12 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.